These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35526927)

  • 21. Impact of nonsegmental vitiligo on patients' health-related quality of life in the United States.
    Daniel SR; Gandhi K; Anastassopoulos KP; Pandya AG; Sikirica V; Patel R; Napatalung L; Yamaguchi Y; Baik R; Ezzedine K
    Br J Dermatol; 2022 Oct; 187(4):603-606. PubMed ID: 35596712
    [No Abstract]   [Full Text] [Related]  

  • 22. Vitiligo and quality of life: the dark face of whiteness.
    Ezzedine K; Eleftheriadou V
    Br J Dermatol; 2018 Jan; 178(1):28-29. PubMed ID: 29357599
    [No Abstract]   [Full Text] [Related]  

  • 23. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage.
    Ongenae K; Dierckxsens L; Brochez L; van Geel N; Naeyaert JM
    Dermatology; 2005; 210(4):279-85. PubMed ID: 15942213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cosmetic camouflage in vitiligo.
    Sarveswari KN
    Indian J Dermatol; 2010; 55(3):211-4. PubMed ID: 21063508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitiligo Impact Scale (VIS)-22: A measure of the psycho-social burden of vitiligo.
    Gupta V; Ramam M
    Indian J Dermatol Venereol Leprol; 2022; 88(5):691-695. PubMed ID: 35962518
    [No Abstract]   [Full Text] [Related]  

  • 26. Rhododendrol-induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo.
    Inoue S; Katayama I; Suzuki T; Tanemura A; Ito S; Abe Y; Sumikawa Y; Yoshikawa M; Suzuki K; Yagami A; Masui Y; Ito A; Matsunaga K
    J Dermatol; 2021 Jul; 48(7):969-978. PubMed ID: 33951216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic options and hot topics in vitiligo with special focus on pediatrics' vitiligo: A comprehensive review study.
    Roohaninasab M; Mansouri P; Seirafianpour F; Naeini AJ; Goodarzi A
    Dermatol Ther; 2021 Jan; 34(1):e14550. PubMed ID: 33200859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Waterproof camouflage age for vitiligo of the face using Cavilon 3M as a spray.
    Tanioka M; Miyachi Y
    Eur J Dermatol; 2008; 18(1):93-4. PubMed ID: 18086608
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cosmetic camouflage for a better quality of life].
    Deshayes P
    Ann Dermatol Venereol; 2008 Feb; 135 Suppl 3():S208-10. PubMed ID: 18342131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cosmetic camouflage for a better quality of life].
    Deshayes P
    Ann Dermatol Venereol; 2009 Oct; 136 Suppl 6():S372-4. PubMed ID: 19931700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo confocal laser scanning microscopy of hypopigmented macules: a preliminary comparison of confocal images in vitiligo, nevus depigmentosus and postinflammatory hypopigmentation.
    Xiang W; Xu A; Xu J; Bi Z; Shang Y; Ren Q
    Lasers Med Sci; 2010 Jul; 25(4):551-8. PubMed ID: 20180143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the trends of outcome measures and quality of life instruments in vitiligo: A systematic review.
    Maghfour J; Shoukfeh R; Hamzavi IH; Ezzedine K; Mohammad TF
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2270-2272. PubMed ID: 37566732
    [No Abstract]   [Full Text] [Related]  

  • 33. Dihydroxyacetone: a safe camouflaging option in vitiligo.
    Rajatanavin N; Suwanachote S; Kulkollakarn S
    Int J Dermatol; 2008 Apr; 47(4):402-6. PubMed ID: 18377610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features.
    Hartmann A; Bedenk C; Keikavoussi P; Becker JC; Hamm H; Bröcker EB
    J Dtsch Dermatol Ges; 2008 Dec; 6(12):1053-9. PubMed ID: 18479500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The contribution of skin camouflage volunteers in the management of vitiligo.
    Ekwegh U
    BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitiligo.
    Le Poole C; Boissy RE
    Semin Cutan Med Surg; 1997 Mar; 16(1):3-14. PubMed ID: 9125760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychological and psychosocial functioning of children with burn scarring using cosmetic camouflage: a multi-centre prospective randomised controlled trial.
    Maskell J; Newcombe P; Martin G; Kimble R
    Burns; 2014 Feb; 40(1):135-49. PubMed ID: 23770131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corrective cosmetics adjunctive to the fields of ophthalmology and plastic surgery.
    Roberts NC
    Ophthalmic Surg; 1988 Feb; 19(2):107-11. PubMed ID: 2964585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrective camouflage in pediatric dermatology.
    Tedeschi A; Dall'Oglio F; Micali G; Schwartz RA; Janniger CK
    Cutis; 2007 Feb; 79(2):110-2. PubMed ID: 17388210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Camouflaging vitiligo using a spray tan.
    Steuer AB; Zampella JG
    Dermatol Online J; 2020 Jul; 26(7):. PubMed ID: 32898413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.